|
Originally published In Press as doi:10.1074/jbc.M100735200 on April 25, 2001
J. Biol. Chem., Vol. 276, Issue 26, 23748-23756, June 29, 2001
Molecular Cloning, Genomic Mapping, and Expression of Two
Secretor Blood Group (1,2)Fucosyltransferase Genes
Differentially Regulated in Mouse Uterine Epithelium and
Gastrointestinal Tract*
Steven E.
Domino §,
Liang
Zhang , and
John B.
Lowe¶ **
From the Department of Obstetrics and Gynecology,
¶ Howard Hughes Medical Institute, and the Department
of Pathology, The University of Michigan Medical School, Ann Arbor,
Michigan 48109-0650
Received for publication, January 25, 2001, and in revised form, April 18, 2001
 |
ABSTRACT |
Fucosylated oligosaccharides have been proposed
to be involved in multiple cell-cell interactions, including mouse
blastocyst adhesion and intestine-microbe interactions. To begin to
define the regulation and function of terminal (1,2)fucosylated
carbohydrates in these and other tissues, we isolated and characterized
a 85-kilobase (kb) genomic region of mouse chromosome 7, 23.2 centimorgans analogous to human chromosome 19q13.3 that encodes three
(1,2)fucosyltransferases. Gene-specific DNA probes from the open
reading frames of the mouse fucosyltransferase genes corresponding to
human FUT1, FUT2, and SEC1
demonstrate distinct tissue-specific expression patterns by Northern
blot analyses. Flow cytometry profiles of cultured cells transfected
with DNA segments containing the open reading frames of the mouse genes
confirm that each encodes an (1,2)fucosyltransferase. In uterus and
colon, a 3.3-kb FUT2 mRNA represents the major
fucosyltransferase gene expressed. Steady-state FUT2
mRNA levels are cyclically regulated during the estrus cycle,
increasing 10-fold from early diestrus to a relative maximum in
proestrus. In contrast, SEC1 and FUT1 do not
show prominently regulated expression in uterus. FUT2
expression localizes to luminal uterine epithelium by in
situ hybridization, implying that this gene determines expression
of cell surface Fuc 1 2Gal epitopes proposed to mediate
blastocyst adhesion.
 |
INTRODUCTION |
Implantation competence of uterine epithelium is
hormone-dependent (1) and is accompanied by morphological
and biochemical changes in the luminal surface of this epithelium (2,
3). Although a variety of molecules have been implicated in the series of adhesive events leading to implantation, including fibronectin and
laminin and their integrin counter-receptors (4-11), cell surface
heparin sulfate proteoglycans (12-16), and mucins (17), there is also
compelling experimental evidence that specific cell surface
glycoconjugates mediate the initial adhesive process (18-22). Specifically, the terminal (1,2)fucosylated oligosaccharide epitope known as the H type 1 moiety undergoes differential expression in the
endometrium and early embryo, exhibits regulation during the mouse
estrus cycle, and is present at a time appropriate for implantation
(23-25). The epitope is also present on uterine epithelium of
ovariectomized mice only after estrogen injection at a time correlated
with endometrial receptivity (24). In addition, exogenous H type 1 oligosaccharide and monoclonal antibodies toward this epitope inhibit
blastocyst adhesion in vitro, whereas isomeric oligosaccharides and isotype-controlled antibodies do not inhibit this
attachment (25). Furthermore, a potential counter-receptor on hatched
mouse blastocysts has been demonstrated by specific binding of
fluorescently labeled H type 1 oligosaccharide (26, 27). This binding
was specific to the apical surface of mural trophectoderm where the
initial adhesion to uterine epithelium is seen in the mouse.
The glycosidic linkages of the H type 1 epitope, like other
oligosaccharides, are catalyzed by the actions of specific
glycosyltransferases (28, 29). The last step in the synthesis of the H
type 1 determinant is catalyzed by an (1,2)fucosyltransferase
activity whose expression is restricted to specific tissues. By genetic
analysis and cloning studies in humans, two fucosyltransferase genes,
FUT11 and
FUT2, are known to be capable of synthesizing (1,2)fucose oligosaccharides such as those found in H type 1 epitopes (30-32). A
third DNA segment in humans (called SEC1) appears to be a
pseudogene containing gene-inactivating frameshift mutations (31,
32).
An (1,2)fucosyltransferase activity has been demonstrated in
preparations of mouse uterine epithelial cells in vitro
(33). This enzymatic activity varied 5-fold during the estrus cycle with the highest activity in estrus (33). In addition, in
ovariectomized mice, the activity was increased in estrogen-treated
animals and inhibited in progesterone-treated animals. Furthermore,
changes in the biochemical activity were correlated with cyclical
changes in mRNA expression in luminal and glandular epithelium by
hybridization in situ using a 650-bp probe from a portion of
the mouse FUT1 coding exon (34). Northern blot analysis with
this probe on uterine RNA identified a single transcript of a size
larger than expected for FUT1, based on our own
characterization of the mouse FUT1 locus (35). Kinetic
analysis using sonicated uterine epithelial samples in vitro
was consistent with the presence of one type of
(1,2)fucosyltransferase activity (34). FUT1 expression
was reported by these authors to decrease during early pregnancy by reverse transcriptase-PCR and confirmed by sequencing of the resulting 358-bp band (34).
Taken together, these experimental data suggest involvement of both the
H type 1 epitope and the enzymes that catalyze the synthesis of this
epitope in blastocyst adhesion. We now identify and characterize three
mouse (1,2)fucosyltransferase genes capable of expressing the H type
1 oligosaccharide. Using relatively short 200-bp gene-specific probes,
we find that steady-state FUT2 mRNA levels are
cyclically regulated during the estrus cycle, increasing ~10-fold
from early diestrus to a relative maximum in proestrus. FUT1
was also detected in uterus but did not show regulated expression and
accumulated at relatively lower steady-state mRNA levels. FUT2 expression localizes to luminal uterine epithelium by
in situ hybridization, implying that this gene determines
expression of cell surface Fuc 1 2Gal epitopes proposed to
mediate blastocyst adhesion.
 |
EXPERIMENTAL PROCEDURES |
Library Screening and Sequence Analysis--
A commercially
available P1 genomic library (strain 129P2/OlaHsd, Incyte Genomics, St.
Louis, MO) was screened using PCR primers that generate a 432-bp
amplicon from the 3'-region of the open reading frame of mouse FUT1
(35): forward primer, 5'-TAC CTT TGT GGG TGT CCA TGT GCG-3' and
backward primer, 5'-GAT GCC CAC CCA CTC GGG CAG G-3'. Positive clones
were transferred by transduction to Escherichia coli NS3516
to increase plasmid yield. Plasmid preparations were performed
according to the manufacture's instructions by alkaline lysis of
isopropyl- -D-thiogalactoside-induced cultures. Restriction digestions were performed with NotI,
SfiI, SalI, and PacI. Restriction
fragments of 2-85 kb were mapped by pulsed field gel electrophoresis
in a 1% agarose gel on a Bio-Rad CHEF Mapper for 16 h at
14 °C, 6 v/cm with switching times of 2.16-6.67 s and a ramping
constant of 0.130. Plasmid Southern blotting (36) using a
double-stranded DNA probe corresponding to the 432-bp PCR amplicon was
performed to identify smaller restriction fragments for subcloning and
sequencing in vector pNEB193 (New England BioLabs, Beverly, MA).
Resulting plasmids were mapped by partial digestion restriction mapping
(37) and DNA sequencing. Automated DNA sequencing was performed on
Applied Biosystems DNA sequencers in the University of Michigan DNA
Sequencing Core Facility. Sequencing runs with overlapping forward and
backward primers were aligned using the program Sequencher (Gene Codes,
Ann Arbor, MI).
Expression Studies in COS-7 Cells--
Expression vectors for
mouse FUT2 and SEC1 were designed using restriction sites obtained from
the DNA sequences around each open reading frame and subcloned into the
expression vector pcDNAI (Invitrogen, Carlsbad, CA). The plasmid
pcDNAI-FUT2 contains the predicted open reading of mouse
FUT2 in a 1.34-kb EcoRV fragment ligated into the
EcoRV site of pcDNAI. The plasmid pcDNAI-SEC1 contains the predicted open reading of mouse SEC1 in a
1.34-kb TfiI/PvuII fragment. The TfiI
overhang was filled in by T4 DNA polymerase (Life Technologies,
Inc.) and ligated into the EcoRV site of pcDNAI.
Correct orientation of the insert was determined by DNA sequencing. The
expression vector pcDNAI- (1,2)FTse containing human
FUT2 was used as a positive control (32). COS-7 cells were
stained 72 h following transient transfection by DOTAP
liposomal transfection reagent (Roche Molecular Biochemicals) with IgM
monoclonal anti-A and -H antibodies (Chembiomed Ltd., Edmonton,
Alberta, Canada) at a concentration of 10 µg/ml. Upon staining with
fluorescein isothiocyanate-conjugated goat anti-murine IgM, cells were
analyzed on a Becton-Dickinson FACScan (35). Enzymatic assay of
(1,2)fucosyltransferase activity in vitro was performed
on extracts from transfected COS-7 cell cultures exactly as previously
described (35).
Southern Blot and Northern Blot Analysis of Mouse FUT2 and
SEC1--
Following sequencing of the open reading frames of
FUT2 and SEC1, PCR primers were used to amplify
DNA probes selective for each gene. Restriction sites for
EcoRI and HindIII (underlined) were added for ease of subsequent isolation from the following plasmids. FUT2: 214-bp probe, forward primer 1, 5'-CGG
AAT TCT GCT TTC TTT CCT GGC AGC C-3'; reverse primer 1, 5'-CCC
AAG CTT TGC AGC TTG GCA CTC TGC TG-3'. SEC1:
208-bp probe, forward primer 2, 5'-CGG AAT TCT CCT GTC TTC
TCT CAC TCA CAG TGC-3'; reverse primer 2, 5'-CCC AAG
CTT TGA TGG TGA ACA TGC CCT CC-3'. The Expand High Fidelity PCR
kit (Roche Molecular Biochemicals, Mannheim, Germany) was used for
amplification of the probe sequences. The resulting DNA fragments were
purified with a Qiagen QIAquick gel extraction kit column (Qiagen,
Valencia, CA), restricted with EcoRI and HindIII,
re-purified, and cloned into pGEM-4Z (Promega, Madison, WI). DNA
sequencing confirmed the correct amplification of the probe sequences.
To obtain probes for Southern and Northern blot analysis, the
FUT2-pGEM4Z and SEC1-pGEM4Z plasmids described above were restricted with EcoRI and HindIII. Double-stranded DNA
probes of 214 and 208 bp were purified and used in Southern blot and
Northern blot analyses following standard protocols (36, 38). To
summarize, total RNA was collected from various flash-frozen mouse
organs and run twice over oligo-dT columns to enrich for polyadenylated RNA. Ultraviolet absorbance at 260 nm was determined for each sample,
and equal amounts (3-5 µg) of polyadenylated RNA from each tissue
were run on formaldehyde agarose gel electrophoresis. The gels were
transferred to nylon membranes (Hybond-N, Amersham Pharmacia Biotech)
and prehybridized overnight in a formamide-based nucleic acid
hybridization buffer. 25 ng of oligonucleotide probes was random-primed
with [32P]dCTP using the Rediprime DNA-labeling system
(Amersham Pharmacia Biotech) resulting in a specific activity of
1-2 × 109 cpm/µg of DNA probe. Blots were
hybridized for 24-36 h, then washed with 2× SSC, 0.2% SDS at room
temperature for 10 min three times, then 0.5× SSC, 0.2% SDS at
65 °C for 15 min twice. Washed blots were quantified on a
PhosphorImager then subjected to autoradiography for the final images.
Other mouse gene studies by Northern blot analysis used previously
published or commercially available probes: FUT1, 347-bp PCR
fragment (35); Fuc-TIV, NcoI-SspI
segment (39); (1,3)Gal-T,
BstEII-PstI segment (40);
-actin, CLONTECH product 7760-C.
Vaginal Cytology and Uterine in Situ Hybridization--
Mice,
strain 129×1/SvJ (Jackson Laboratory, Stock no. 000691), 8-9 weeks
old, were followed by examination of vaginal cytology through at least
two estrus cycles (41). Uteri from 4-5 mice in each stage of the
estrus cycle were collected for Northern analysis as above and for
in situ hybridization. In situ hybridization was
performed on 10-µm frozen sections of mouse uteri as previously described using FUT1- and FUT2-specific probes
(35, 42). The 228-bp FUT1 probe corresponds to bp 81-308 of
the FUT1 open reading frame (35). The 214-bp FUT2
probe corresponds to bp 20 to 194 of the FUT2 open reading
frame. To compare in situ hybridization with the previously
published study of FUT1 expression in uterus, a less
selective 530-bp FUT1 probe that shares 70% similarity between FUT1 and FUT2 was derived from an
EcoRI/PstI fragment corresponding to bp 556-1085
of the FUT1 open reading frame uterus (34). Frozen sections
of mouse uteri were processed in duplicate. Each slide contained
adjacent sections for hybridization with antisense and sense control
probes. Single-stranded RNA probes were synthesized with
[35S]UTP using the Riboprobe transcription kit (Promega)
from T7 and Sp6 promoters as previously described (35) using linearized plasmids. After hybridization under glass coverslips overnight, slides
were washed twice under high stringency (50% formamide, 2× SSC, 20 mM dithiothreitol at 65 °C for 30 min), dipped in
photographic emulsion, and exposed for 2-4 weeks at 4 °C. Slides
were developed and examined under darkfield microscopy.
 |
RESULTS |
Molecular Cloning of an 85-kb Genomic Segment Containing the Open
Reading Frames of Three (1,2)Fucosyltransferase Genes--
Because
the three human (1,2)fucosyltransferase genes are physically linked
within an 65-kb region of human chromosome 19, it was reasoned that a
similar linkage may be found in the mouse (31). A P1 phage library was
chosen for screening because of the relatively large insert size in P1
clones of 75-95 kb (43). Because the three human
(1,2)fucosyltransferase genes showed the highest degree of sequence
similarity in their 3'-regions (32), PCR primers for the P1 screening
were chosen from the presumed catalytic region in the 3'-end of a
previously cloned mouse FUT1 open reading frame (35) to
maximize the potential cross-hybridization with several
(1,2)fucosyltransferase genes.
Four positive P1 clones with inserts of 70-85 kb were obtained by
screening a mouse genomic P1 library (see "Experimental Procedures"). The clones were characterized by pulsed field gel electrophoresis restriction mapping and plasmid Southern blotting using
probes derived from mouse FUT1. Upon subcloning and
sequencing of the largest clone, three (1,2)fucosyltransferase open
reading frames were obtained (Fig.
1A). From the T7-end of the P1
vector, 9257 bp were sequenced, including the open reading frame of
FUT1 (GenBankTM accession number AF214655). The DNA coding
sequence of 129P2/OlaHsd mouse FUT1 was identical to our
previously published sequence of NIH Swiss mouse FUT1 (35).
From the Sp6 site of the P1 vector, nine overlapping subclones were
serially mapped by EcoRI restriction digestion and plasmid
Southern blotting (Fig. 1B). Open reading frames for mouse
genes FUT2 (GenBankTM AF214656) and SEC1
(GenBankTM AF214657) were determined by sequencing 6762-bp and 4705-bp
contigs, and are similar to GenBankTM accession number sequences
AF064792 and Y09882/AF113532, respectively. The order and
relative spacing of the three loci (FUT1, FUT2, and SEC1) on mouse chromosome 7, 23.2 centimorgans (35), is similar to the homologous genes on human chromosome 19q13.3 (31) and
implies gene duplication, as has been postulated for the human FUT1 and
FUT2 loci.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 1.
Physical map of
(1,2)fucosyltransferase open reading frames on
mouse chromosome 7. A, physical map of an
85-kb genomic P1 insert containing all three mouse
(1,2)fucosyltransferase. The P1 insert was mapped by single, double,
and partial digestions. The locations of the opening reading frames
(solid rectangles) for FUT1, FUT2, and
SEC1 were determined by DNA sequencing of subclones
generated from the insert. Scale shows distance in kilobases.
Restriction enzymes mapped included PacI (P),
SalI (S), and NotI (N).
B, EcoRI mapping of overlapping genomic contigs
encompassing mouse SEC1 and FUT2 open-reading
frames. The 85-kb P1 insert depicted in A was subcloned from
the Sp6 end by sequential cloning using DNA probes shown. The
top line depicts physical distance in kilobases between
restriction sites used for subcloning. The restriction sites shown in
boldface represent the PacI and SalI
sites from the 3'-end of the 85-kb genomic segment. Vertical
bars along each subclone depict unique EcoRI
sites.
|
|
Restriction Map and Sequence Comparison of Mouse FUT2 and SEC1 Open
Reading Frames--
Mouse FUT2 and SEC1 are encoded by single open
reading frames contained within relatively small continuous genomic DNA
segments (Fig. 2A). The human
FUT2 locus also maintains a single coding exon, although
there are one or possibly more 5'-exons derived from this human gene.
We do not yet know if the mouse FUT2 is similar in this
regard, because we have not yet characterized the structures of mouse
FUT2 cDNAs. When compared with the orthologous human
fucosyltransferases, mouse FUT2 and SEC1 display
82% and 77%, respectively, nucleotide sequence identity (Fig.
2B). The corresponding mouse polypeptides predicted by these
open reading frames show conservation of type-2 transmembrane topology,
because each is predicted to maintain short intracellular amino
termini, transmembrane regions of 14-20 amino acid residues, and
conservation of predicted N-glycosylation sites.

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 2.
Restriction map and sequence analysis of
mouse FUT2 and SEC1
(1,2)fucosyltransferase genes. A,
schematic diagram of mouse FUT2 and SEC1 loci.
The open boxes indicate the position of the open reading
frames whose deduced amino acid sequences are depicted in B.
The position of subclones used for in vitro
(1,2)fucosyltransferase expression assays are shown as closed
boxes. PCR primer locations for gene-specific probes used in
Southern blotting, Northern blotting, and in situ
hybridization are shown below each open reading frame. The
numbers adjacent to the closed boxes correspond to base
pairs of the end of each subclone or probe, relative to the start codon
of the respective open reading frame. B, comparison of
derived amino acid sequences of mouse and human FUT2 and
SEC1 open reading frames. Vertical lines denote
identical nucleotides. The putative transmembrane regions are depicted
as closed rectangles near the 5'-end of each gene. Potential
asparagine-linked glycosylation sites are indicated with the
Y-shaped symbol. C, comparison of percent
nucleotide identity between FUT2 and SEC1. The
sequences of the open reading frames of FUT2 and
SEC1 were compared in 50-bp increments. The 5'-ends
contained the region of least similarity. Gene-specific probes were
designed from the first 200 bases of the 5'-end of the mouse Secretor
genes to avoid the high degree of sequence similarity found throughout
most of the open reading frames.
|
|
In contrast to the human gene, the coding region of mouse
SEC1 extends beyond the region in human SEC1
where a 2-base pair deletion results in a frameshift and consequent
inactivation of fucosyltransferase activity. Mouse SEC1
maintains an in-frame translation similar to FUT2, including
a high degree of sequence similarity to FUT2, and
conservation of three predicted N-glycosylation sites. The
open reading frames of mouse FUT2 and SEC1 share
75% sequence identity overall, with 50-bp regions that vary from 25% to 99% identity (Fig. 2C).
Expression of Mouse FUT2 and SEC1 in Cultured Cells--
Our
previous studies have documented that mouse FUT1 encodes an
(1,2)fucosyltransferase (35). To determine if the genomic DNA
sequences for FUT2 and SEC1 encode functional
(1,2)fucosyltransferases, 1.3-kb restriction fragments containing
the open reading frames of each gene were cloned into mammalian
expression vectors, sequenced to assure correct orientation, and
transiently transfected into COS-7 cells as described under
"Experimental Procedures." In our previous studies, we found that
blood group A and B glycosyltransferases are expressed in COS-7 cells,
whereas (1,2)fucosyltransferase, and H blood group molecules, are
absent from these cells (35). Because H blood group molecules are used
as substrates by the A and B transferases, the A and B transferases in
COS-7 cells thus cannot form A or B antigens. However, when transfected
with an (1,2)fucosyltransferase expression vector, the cells can
then form H blood group molecules, and these can in turn be used as substrates by the A and B transferases to form A and B blood antigens (35). In the present analysis, anti-H and anti-A antibodies were used
in similar flow-cytometry analyses on COS-7 cells transiently transfected with expression constructs for FUT2 and SEC1. Mouse FUT2
demonstrates accumulation of A and H antigens (Fig.
3). Although significantly lower in
apparent activity compared with human and mouse FUT2, cells transfected
with the mouse SEC1 vector also accumulate A and H antigens.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 3.
Flow cytometry profiles of cell surface H and
A blood group epitope expression by COS-7 cells transfected with mouse
SEC1 and FUT2 expression
vectors. COS-7 cells were transiently transfected with expression
vectors containing either no insert (negative control) or the open
reading frames of human FUT2 (positive control), mouse
SEC1, or mouse FUT2 as described under
"Experimental Procedures." After a 72-h expression period, cells
were collected, stained with IgM monoclonal antibodies to the H blood
group (A) and the A blood group (B).
|
|
To compare the mouse enzymes to human FUT2, the apparent
Michaelis-Menten constant (Km) for the
artificial substrate phenyl- -D-galactoside was assayed
in extracts from transiently transfected COS-7 cells (see
"Experimental Procedures"). While authentic
(1,2)fucosyltransferase acceptors include O- and N-linked type I and II glycans as well as glycolipids,
phenyl- -D-galactoside is typically chosen as a
representative acceptor because of its ease of purification. Extracts
from cells transfected with FUT2 fucosylate
phenyl- -D-galactoside with an apparent Michaelis-Menten constant (Km) of 10.2 mM. This
Km is similar to the Km
determination for this substrate using human FUT2 (11.5 mM
(32)) (Fig. 4). Unexpectedly, the
expression vector containing the open reading frame of SEC1 had no
detectable fucosyltransferase activity in this assay under
circumstances where we identify cell surface H and A epitopes in
SEC1-transfected cells. These observations suggest that the
physiological acceptors for SEC1, some of which must be made by COS
cells, are not highly similar to the in vitro substrate
phenyl- -D-galactoside

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 4.
Fucosyltransferase activity of extracts from
COS-7 cells transfected with mouse FUT2 expression vector.
A, catalytic activity of FUT2 transfection extracts on
increasing concentrations of acceptor substrate
phenyl- -D-galactoside. COS-7 cells were transfected with
an expression vector containing the open reading frame of FUT2, and
fucosyltransferase activity was measured in cell extracts as
described under "Experimental Procedures." B, apparent
Michaelis-Menten constant for phenyl- -D-galactoside. The
apparent Michaelis-Menten constant (Km) was 10.2 mM. Expression vectors containing the presumed open reading
frame of SEC1 had no detectable fucosyltransferase activity in parallel
experiments despite equal transfection efficiency as measured by
co-transfection of chloramphenicol acetyltransferase.
|
|
Tissue-specific Expression Patterns of Mouse FUT2 and SEC1--
To
study mRNA expression of the FUT2 and SEC1 loci, we sought to
generate relatively short gene-specific DNA probes with less than 35%
sequence identity, because the open reading frames of FUT2 and SEC1
contain long regions of 75% to 99% similarity. From the 5'-coding
regions, ~200 bp of each gene were subcloned by PCR (see
"Experimental Procedures"; Fig.
5A). To test the specificity of the probes, Southern blot analyses were performed (Fig.
5B). The FUT2 214-bp and SEC1 208-bp probes identify single
bands (Fig. 5B).

View larger version (64K):
[in this window]
[in a new window]
|
Fig. 5.
Southern blot analysis with mouse
FUT2 and SEC1 probes.
A, sequence alignment of gene-specific DNA probes. The
sequences of FUT2 and SEC1 in the region of the
gene-specific probes are aligned. Vertical bars denote
nucleotide identity. Forward primer 1 and backward primer 1 generate
a 214-bp FUT2-specific probe. The predicted translation
start codon are marked "+1." Forward primer 2 and
backward primer 2 generate a 208-bp SEC1-specific probe.
B, mouse genomic DNA (129×1/SvJ) was digested to completion
with the indicated restriction enzymes and subjected to Southern blot
analysis (see "Experimental Procedures"). Parallel blots were
processed and hybridized with the FUT2 5'-probe and the
SEC1 5'-probe. Blots were washed under high stringency (see
"Experimental Procedures") and subjected to autoradiography as
shown.
|
|
Using these gene-specific probes, Northern blot analysis discloses that
FUT2 and SEC1 show distinct patterns of mRNA
expression in adult tissues (Fig. 6). The
FUT2 probe identifies a single transcript of ~3.3 kb
expressed most abundantly in uterus, stomach, and colon, and at a lower
level on ovary. In contrast, the SEC1 probe hybridizes to
multiple transcripts in testes/epididymis and thymus. The major
transcript is 2.6 kb in size, and additional transcripts of ~2.3,
1.6, and 1.3 kb in size are also identified. The SEC1 probe
also cross-hybridizes to multiple faint bands in other tissues.
Although these may represent partially processed or alternatively
spliced forms of authentic SEC1 transcripts, or transcripts
emanating from other genes, their precise nature is not yet known. As a
comparison to these expression patterns, the hybridization pattern of
the major FUT1 transcript we have previously described in
the same tissues is also shown (35).

View larger version (102K):
[in this window]
[in a new window]
|
Fig. 6.
Northern blot analysis of three mouse
(1,2)fucosyltransferase transcripts in adult mouse
tissues. Multiple Northern blots were prepared and hybridized as
described under "Experimental Procedures." Each lane contains 3 µg of polyadenylated mRNA isolated from the mouse tissues
indicated above each lane. Each blot was probed using
gene-specific probes corresponding to FUT1, FUT2,
or SEC1. Transcript sizes, in kilobases, were estimated from
[35S]RNA markers.
|
|
To directly determine if the changes in uterine (1,2)fucosylated
glycans and (1,2)fucosyltransferase activity observed during the
rodent estrus cycle (33) correspond to alteration in fucosyltransferase mRNA accumulation and, if so, to determine how each of these three loci may contribute to this process, Northern blot analyses were completed using mRNA prepared from uteri taken during each stage of
the estrus cycle. Northern blot analysis of uterine polyadenylated RNA
from early diestrus, late diestrus, proestrus, estrus, and metestrus 2 demonstrates that FUT2 represents the major
(1,2)fucosyltransferase gene expressed in mouse uterus (Fig.
7). By PhosphorImager quantification, levels of FUT2 transcripts are greatest in proestrus and
estrus, with 10- to 12-fold increases over early diestrus. Steady-state FUT1 transcript levels represent <5% of that of
FUT2 when compared with Northern blot probes of similar
specific activity, but also show a 2- to 3-fold increase in
steady-state levels from early diestrus to proestrus (second row),
similar to the variation in steady-state actin mRNA during the
estrus cycle. The apparent variation in FUT1 transcript
accumulation may thus reflect slight differences in the amounts of
mRNA loaded in each lane of the Northern blot or may reflect some
subtle regulation of the FUT1 locus during the cycle. Two
unrelated glycosyltransferase genes whose corresponding carbohydrate
epitopes are not known to be regulated in the estrus cycle,
(1,3)fucosyltransferase IV (Fuc-TIV) and
(1,3)galactosyltransferase ( (1,3)Gal-T),
show constitutive expression in uterus by Northern analysis.

View larger version (81K):
[in this window]
[in a new window]
|
Fig. 7.
Cyclic regulation of mouse
(1,2)fucosyltransferase gene mRNA during the
estrus cycle. Female 129×1/SvJ mice were followed through the
estrus cycle as described under "Experimental Procedures." For each
stage of the cycle, uteri from four to five mice were processed
to collect polyadenylated RNA. Equal amounts of polyadenylated RNA (4 µg) were separated by formaldehyde agarose gel electrophoresis and
transferred to Hybond-N membranes. Duplicate blots were hybridized with
probes for either FUT2 (top row) or
FUT1 (second row). After autoradiography, both
blots were probed for -actin (third row). The blots were
stripped and probe with two additional glycosyltransferase genes that
are expressed in uterus (Fuc-TIV and
Gal-T).
|
|
To determine which cell types within the uterus express
FUT2, frozen sections of mouse uteri during the estrus cycle
were analyzed by in situ hybridization. Specific binding of
the FUT2 antisense probe is detected in uterine luminal
epithelial cells, whereas the FUT1 antisense probe shows no
specific signal (Fig. 8). In contrast, a
less selective FUT1 probe (see "Experimental Procedures") that shares 70% similarity between FUT1 and
FUT2 shows a signal in epithelial cells most likely due to
cross-hybridization with FUT2 transcripts.

View larger version (113K):
[in this window]
[in a new window]
|
Fig. 8.
Localization of mouse FUT2
message to uterine epithelium during proestrus by in
situ hybridization. Female 129×1/SvJ mice were
followed through the estrus cycle by examination of vaginal washings.
Uteri were flash-frozen in liquid nitrogen. Serial cryosections of
10-µm thickness were subjected to in situ hybridization as
described under "Experimental Procedures." Adjacent sections were
hybridized with 35S-antisense and sense (control) probes.
After 30 days of exposure, emulsions were developed and the tissue
counter-stained with hematoxylin and eosin. Shown are hematoxylin and
eosin microphotographs along with the darkfield microphotographs of
serial sections of uterine epithelium at 250× magnification. Note
equal intensity of silver grains (bright dots) in background
areas, whereas uterine epithelial cells show specific staining with the
antisense probe for FUT2, but not FUT1. In
contrast, a less selective FUT1 probe (see "Experimental
Procedures" and Ref. 34) that is reactive with both FUT1
and FUT2 shows a signal in epithelial cells likely due to
cross-hybridization with FUT2 transcripts.
|
|
 |
DISCUSSION |
A wide variety of (1,2)fucosylated glycans have been described
in humans, mice, and other mammals (44). Expression of these terminal
glycan structures is precisely regulated during development, in a
tissue-specific manner in the postnatal period, and is characterized by
dynamic expression in several physiological and pathological contexts.
However, definitive functional correlates for the careful regulation of
these structures remain elusive. To identify such functions in the
context of an intact mammalian organism, we have sought to develop
strains of mice with induced mutations in the (1,2)fucosyltransferase loci that control the expression of
(1,2)fucosylated glycoconjugates. A first step in this process
involves the isolation and characterization of the cognate
(1,2)fucosyltransferase genes. We report here the characterization
of three closely linked mouse (1,2)fucosyltransferase loci that
correspond to the human H and Se blood group
(1,2)fucosyltransferase genes, and a human
(1,2)fucosyltransferase pseudogene.
A 100-kb genomic region of human chromosome 19q13.3 contains the three
human (1,2)fucosyltransferase loci (31). In rabbits, three
(1,2)fucosyltransferases with sequence similarity to the human loci
each demonstrate enzymatic activity in expression constructs, including rabbit SEC1 (45, 46). Although the chromosomal
locations of the rabbit (1,2)fucosyltransferase loci have not been
mapped, all three (1,2)fucosyltransferase loci are contained on a
single 90-kb genomic segment in rabbits (46). In this study, the three mouse (1,2)fucosyltransferase loci are conserved with similar spacing and order between humans and mice (FUT1,
FUT2, SEC1), consistent with gene duplication of
an ancestral (1,2)fucosyltransferase gene into FUT1
and FUT2, followed by a second duplication of
FUT2 producing SEC1 (47).
The SEC1 locus in mice predicts a protein of similar size to
the other members of the (1,2)fucosyltransferase family and is
clearly transcribed in a tissue-specific manner. However, the recombinant product of this locus in mice did not give clear activity when tested with one prototypical substrate in vitro,
suggesting the possibility that this polypeptide does not exhibit
(1,2)fucosyltransferase activity. However, dozens of known mammalian
glycans have been described with potential for utilization as an
acceptor substrate for this SEC1 locus-encoded
protein (i.e. type 1-6 glycans, fucosyl GM1, and other glycolipids). Such substrates have yet to be
tested in vitro with this protein and remain candidates for
SEC1-dependent fucosylation. In addition, the attendant
possibility exists that mouse SEC1 may act on novel acceptors. For
example, a schistosome (1,2)fucosyltransferase has been documented
to add an (1,2)fucose to an (1,3)fucose (48), although such
activity is as yet unprecedented in mammalian species. There is also
the possibility that the SEC1 protein is not an
(1,2)fucosyltransferase but may have other functions, enzymatic of
otherwise. These issues remain to be explored experimentally.
Multiple lines of evidence support the hypothesis that adhesive
interactions between the mouse blastocyst and the uterine epithelium
during implantation involves a specific (1,2)fucosylated carbohydrate epitope. The H type 1 moiety undergoes differential expression in luminal epithelium of the endometrium and exhibits hormonal regulation during the mouse estrus cycle and in ovariectomized mice at a time correlated with endometrial receptivity (23-25). In vitro experiments demonstrate that fluorescently labeled
H type 1 oligosaccharide binds specifically to hatched mouse
blastocysts and imply the existence of a counter-receptor for H type
1glycans on the blastocyst (26, 27). The hypothesis is supported by in vitro blastocyst adhesion assays, where exogenous H type
1 oligosaccharide and monoclonal antibodies toward this epitope specifically inhibit blastocyst adhesion in vitro (25).
Because very little is known about the expression of fucosylated
glycans and their corresponding fucosyltransferases in the uterus of
other mammals, it remains to be determined if these observations will apply generally to other species. In rat uterus, carbohydrate antigens
based on the Gal- -1-GlcNAc backbone structure are expressed but
include some carbohydrate antigens not expressed in mouse (A and B
antigen) or under different steroidal regulation (H type 1) (49).
The studies we report here identify FUT2 as the mouse
(1,2)fucosyltransferase gene responsible for directing expression of (1,2)fucosyltransferase activity, and presumably H type 1 structures, in the mouse uterus. FUT2 mRNA levels are
regulated in the uterus, either by transcription or mRNA stability,
during the estrus cycle. The expression pattern of FUT2
during the estrus cycle parallels the known (1,2)fucosyltransferase
activity detected in uterine epithelial preparations in
vitro such that the highest level of its mRNA occurred in
proestrus, 12-24 h preceding the maximal enzymatic activity
seen in estrus. By in situ hybridization, accumulation of
FUT2 transcripts is maximal in the luminal epithelium of the uterus during proestrus. This location, and timing, are coincident with
the elaboration of the luminal, cell surface, (1,2)fucosylated H
type 1 epitopes also observed in this physiological context. By
contrast, FUT1 mRNA accumulates to levels representing
<5% of that of levels achieved by FUT2, as assessed by
Northern blotting, using FUT1 and FUT2 probes of
similar specific activity. We observe a 2- to 3-fold increase in
steady-state levels of FUT1 transcripts between early
diestrus and proestrus; this modest increase is minimally greater than
the variation in steady-state levels of actin mRNA during the
estrus cycle. FUT2 transcripts were more abundant than
steady-state FUT1 transcripts, and varied more dramatically during the estrus cycle, from 10- to 12-fold.
FUT1 was the first mouse (1,2)fucosyltransferase
molecularly cloned (35) and has been proposed to be responsible for
regulation of (1,2)fucosylated H type 1 epitopes in uterine
epithelium. An estrogen-dependent
(1,2)fucosyltransferase activity is observed to vary 5-fold during
the estrus cycle, when assessed using mouse uterine epithelial cells
isolated from mice during the cycle (33). Using a 650-bp DNA probe
encoding ~50% of the FUT1 open reading, and in
situ hybridization procedures, Sidu and Kimber (34) detected cyclical changes in the accumulation of a cognate mRNA in uterine luminal and glandular epithelium. Northern blot analysis with this
probe on uterine RNA identified a single transcript of a size larger
than expected for FUT1, although DNA sequence analysis of a
358-bp reverse transcriptase-PCR product from uterine epithelium aligned with a portion of FUT1. Our observations indicate
that FUT2 transcripts accumulate to a substantially greater
level than FUT1 transcripts in the mouse uterine epithelium.
We estimate that the in situ hybridization probe used by
Sidu and Kimber (34) to assign FUT1 expression to moue
uterine epithelia shares 70% sequence similarity with the
corresponding segment of FUT2. Thus, in the in
situ hybridization experiments reported by these authors (34),
cross-hybridization of this probe with FUT2 transcripts that
are abundant in uterine epithelia could have led to misassignment of
these as FUT1-derived. Indeed, our own in situ
hybridization analyses indicate that a FUT2-specific probe
identifies transcripts in uterine epithelial cells, whereas a
FUT1-specific probe does not react with transcripts in these
cells. In our hands, a non-selective probe corresponding to the one
used by Sidu and Kimber (34) does indeed hybridize to uterine
epithelia; but, when considered with our in situ data using
FUT1- or FUT2-specific probes and with the fact
that FUT2 mRNA accumulates in the uterus to a much higher steady-state level compared with FUT1, these results
indicate that, in uterine epithelial cells, this non-selective probe
identifies FUT2 transcripts and not FUT1
transcripts. Kinetic analysis of (1,2)fucosyltransferase activity
in vitro is also consistent with the presence of one type of
(1,2)fucosyltransferase (34). Considered together, these data
indicate that FUT2 represents the major
(1,2)fucosyltransferase gene expressed in mouse uterus. Further
analysis of FUT1 and FUT2 functions in
blastocyst-uterine epithelium interactions will be aided by molecular
characterization of these genes and can be further tested in systems
such as genetically manipulated mice.
Cell surface expression of (1,2)fucosylated oligosaccharides has
also been explored in the gastrointestinal tract; the nature of the
fucosyltransferases responsible for regulating these structures in that
tissue is clarified to some extent by our studies. Lectin binding
studies demonstrate complex developmental programs for expression of
fucosylated oligosaccharides in the gastric-colonic and crypt-villus
axes (50) and imply an interesting dependence on bacterial colonization
of the intestine (51). Whereas the epithelium of ileum of
conventionally housed mice is characterized by a complex
cell-type-specific expression pattern of (1,2)fucosylated glycoconjugates, the intestine of a germ-free mouse is virtually deficient in such fucosylated glycans. Colonization of germ-free mice
with Bacteroides thetaiotaomicron stimulates expression of (1,2)fucose epitopes by the ileal enterocyte, in coincidence with
accumulation of a previously unidentified (1,2)fucosyltransferase mRNA as assessed by an reverse transcriptase-PCR approach. By contrast, colonization with an isogenic strain of B. thetaiotaomicron defective in L-fucose metabolism is
not accompanied by induction of (1,2)fucosyltransferase gene
expression (51). A comparison of the sequences of the PCR primers used
by Bry and colleagues (51) with the three mouse
(1,2)fucosyltransferase genes we characterize here indicates that
the primers were derived from the 3'-region where SEC1 and FUT2 are
nearly identical and allows us to conclude that either SEC1 or FUT2
could have been amplified in their studies.
Dynamic and tissue-specific expression of (1,2)fucosylated
oligosaccharides has been observed in other, anatomically related physiological and pathological contexts, although little is yet known
about the (1,2)fucosyltransferase genes responsible for such
control. For example, the (1,2)fucosyltransferase activity in the
rat small intestine varies developmentally, in response to
hydrocortisone during suckling, and by nutritional state (52-54). Conventionalization of ex-germ free mice stimulates fucosylation of the
glycolipid GM1, in concert with increases in expression of major
histocompatibility complex class II molecules and Thy-1 and induction
of cytolytic activity of intraepithelial lymphocytes (55). These
observations suggest a role for (1,2)fucosylated oligosaccharides in
the development of the mucosal architecture and immune system of the
small intestine (55). This general notion is supported by the
observation that mouse Peyer's patch follicle-associated epithelial
cells endocytose and transcytose the (1,2)fucose-specific lectin
Ulex europaeus agglutinin-I (UEA-I) in a gut-loop in
vivo model that may recapitulate microorganism adhesion and uptake
(56), and by the observation that UEA-I lectin binding to dome
epithelium of gut-associated lymphoid tissues exhibits developmental
regulation (57). In thymus, medullary epithelial cells are labeled by
[3H]fucose (58), and (1,2)fucose epitopes have been
demonstrated in the thymic medulla of mice by binding of the lectin
UEA-I (59). Nonetheless, a critical role for (1,2)fucosylated
epitopes in the thymus is not yet known, even though
carbohydrate-lectin interactions have been implicated in several
immune-related activities (60). The identity of the
(1,2)fucosyltransferase loci responsible for control of these
processes will be facilitated by the sequences we report here.
Importantly, insight into the functional relevance of these
observations should be facilitated by generation and analysis of mice
with induced null mutations at the FUT1, FUT2, or
SECI loci.
 |
ACKNOWLEDGEMENTS |
We are grateful to Bronia Petryniak and
Suzanne Genik for technical assistance.
 |
FOOTNOTES |
*
This work was supported in part by a fellowship grant from
the Reproductive Scientist Development Program and by National Institutes of Health Grants K08 HD01195 (to S. E. D) and P01
CA71932 (to J. B. L).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
**
An Investigator of the Howard Hughes Medical Institute.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF214655, AF214656, AF214657, and AF214658.
§
To whom correspondence should be addressed: 6428 Medical Science
Bldg. I, 1150 West Medical Center Dr., The University of Michigan, Ann
Arbor, MI 48109-0617. Tel.: 734-647-9562; Fax 734-936-8617; E-mail:
sedomino@med.umich.edu.
Published, JBC Papers in Press, April 25, 2001, DOI 10.1074/jbc.M100735200
 |
ABBREVIATIONS |
The abbreviations used are:
FUT1, (1,2)fucosyltransferase H locus;
FUT2, (1,2)fucosyltransferase Secretor locus;
SEC1, (1,2)fucosyltransferase third locus;
bp, base pair(s);
kb, kilobase pair(s);
PCR, polymerase chain reaction;
Fucosyl GM1, Fuc 1,2Gal 1,3GalNAc 1,4(NeuAc 2,3)Gal 1,4Glc 1,1ceramide;
UEA-I, Ulex europaeus agglutinin-I.1.
 |
REFERENCES |
| 1.
|
Harper, M. J.
(1992)
Baillieres Clin. Obstet. Gynaecol.
6,
351-371
|
| 2.
|
Svalander, P. C.,
Odin, P.,
Nilsson, B. O.,
and Obrink, B.
(1990)
J. Reprod. Fertil.
88,
213-221
|
| 3.
|
Enders, A. C.
(1976)
J. Reprod. Fertil. Suppl.
25,
1-15
|
| 4.
|
Armant, D. R.,
Kaplan, H. A.,
and Lennarz, W. J.
(1986)
Dev. Biol.
116,
519-523
|
| 5.
|
Armant, D. R.,
Kaplan, H. A.,
Mover, H.,
and Lennarz, W. J.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
6751-6755
|
| 6.
|
Sutherland, A. E.,
Calarco, P. G.,
and Damsky, C. H.
(1988)
J. Cell Biol.
106,
1331-1348
|
| 7.
|
Feinberg, R. F.,
Kliman, H. J.,
and Lockwood, C. J.
(1991)
Am. J. Pathol.
138,
537-543
|
| 8.
|
Sutherland, A. E.,
Calarco, P. G.,
and Damsky, C. H.
(1993)
Development
119,
1175-1186
|
| 9.
|
Cross, J. C.,
Werb, Z.,
and Fisher, S. J.
(1994)
Science
266,
1508-1518
|
| 10.
|
Lessey, B. A.,
Damjanovich, L.,
Coutifaris, C.,
Castelbaum, A.,
Albelda, S. M.,
and Buck, C. A.
(1992)
J. Clin. Invest.
90,
188-195
|
| 11.
|
Lessey, B. A.,
Castelbaum, A. J.,
Buck, C. A.,
Lei, Y.,
Yowell, C. W.,
and Sun, J.
(1994)
Fertil. Steril.
62,
497-506
|
| 12.
|
Farach, M. C.,
Tang, J. P.,
Decker, G. L.,
and Carson, D. D.
(1987)
Dev. Biol.
123,
401-410
|
| 13.
|
Carson, D. D.,
Tang, J. P.,
and Julian, J.
(1993)
Dev. Biol.
155,
97-106
|
| 14.
|
Wilson, O.,
Jacobs, A. L.,
Stewart, S.,
and Carson, D. D.
(1990)
J. Cell. Physiol.
143,
60-67
|
| 15.
|
Carson, D. D.,
Rohde, L. H.,
and Surveyor, G.
(1994)
Int. J. Biochem.
26,
1269-1277
|
| 16.
|
Das, S. K.,
Wang, X. N.,
Paria, B. C.,
Damm, D.,
Abraham, J. A.,
Klagsbrun, M.,
Andrews, G. K.,
and Dey, S. K.
(1994)
Development
120,
1071-1083
|
| 17.
|
Surveyor, G. A.,
Gendler, S. J.,
Pemberton, L.,
Das, S. K.,
Chakraborty, I.,
Julian, J.,
Pimental, R. A.,
Wegner, C. C.,
Dey, S. K.,
and Carson, D. D.
(1995)
Endocrinology
136,
3639-3647
|
| 18.
|
Dutt, A.,
Tang, J. P.,
and Carson, D. D.
(1987)
Dev. Biol.
119,
23-37
|
| 19.
|
Dutt, A.,
Tang, J. P.,
and Carson, D. D.
(1988)
J. Biol. Chem.
263,
2270-2279
|
| 20.
|
Chavez, D. J.,
and Anderson, T. L.
(1985)
Biol. Reprod.
32,
1135-1142
|
| 21.
|
Barbiaz, B. S.,
and Hathaway, H. J.
(1988)
Biol. Reprod.
39,
699-706
|
| 22.
|
Kliman, H. J.,
Feinberg, R. F.,
Schwartz, L. B.,
Feinman, M. A.,
Lavi, E.,
and Meaddough, E. L.
(1995)
Am. J. Pathol.
146,
166-181
|
| 23.
|
Kimber, S. J.,
Lindenberg, S.,
and Lundblad, A.
(1988)
J. Reprod. Immunol.
12,
297-313
|
| 24.
|
Kimber, S. J.,
and Lindenberg, S.
(1990)
J. Reprod. Fertil.
89,
13-21
|
| 25.
|
Lindenberg, S.,
Sundberg, K.,
Kimber, S. J.,
and Lundblad, A.
(1988)
J. Reprod. Fertil.
83,
149-158
|
| 26.
|
Lindenberg, S.,
Kimber, S. J.,
and Kallin, E.
(1990)
J. Reprod. Fertil.
89,
431-439
|
| 27.
|
Yamagata, T.,
and Yamazaki, K.
(1991)
Biochem. Biophy. Res. Commun.
181,
1004-1009
|
| 28.
|
Hagopian, A.,
and Eylar, E. H.
(1968)
Arch. Biochem. Biophys.
128,
422-433
|
| 29.
|
Sadler, J. E.
(1984)
in
Biology of Carbohydrates
(Ginsburg, V.
, and Robbins, P. W., eds)
, pp. 200-287, Wiley, New York
|
| 30.
|
Larsen, R. D.,
Ernst, L. K.,
Nair, R. P.,
and Lowe, J. B.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
6674-6678
|
| 31.
|
Rouquier, S.,
Lowe, J. B.,
Kelly, R. J.,
Fertitta, A. L.,
Lennon, G. C.,
and Giorgi, D.
(1995)
J. Biol. Chem.
270,
4632-4639
|
| 32.
|
Kelly, R. J.,
Rouquier, S.,
Giorgi, D.,
Lennon, G. G.,
and Lowe, J. B.
(1995)
J. Biol. Chem.
270,
4640-4649
|
| 33.
|
White, S.,
and Kimber, S. J.
(1994)
Biol. Reprod.
50,
73-81
|
| 34.
|
Sidu, S. S.,
and Kimber, S. J.
(1999)
Biol. Reprod.
60,
147-157
|
| 35.
|
Domino, S. E.,
Hiraiwa, N.,
and Lowe, J. B.
(1997)
Biochem. J.
327,
105-115
|
| 36.
|
Brown, T.
(1993)
in
Current Protocols in Molecular Biology
(Ausubel, F. M.
, Brent, R.
, Kingston, R. E.
, Moore, D. D.
, Seidman, J. G.
, Smith, J. A.
, and Struhl, K., eds)
, pp. 2.9.1-2.9.15, Wiley, New York
|
| 37.
|
Bloch, K. D.
(1987)
in
Current Protocols in Molecular Biology
(Ausubel, F. M.
, Brent, R.
, Kingston, R. E.
, Moore, D. D.
, Seidman, J. G.
, Smith, J. A.
, and Struhl, K., eds)
, pp. 3.3.2-3.3.2, Wiley, New York
|
| 38.
|
Brown, T.,
and Mackey, K.
(1997)
in
Current Protocols in Molecular Biology
(Ausubel, F. M.
, Brent, R.
, Kingston, R. E.
, Moore, D. D.
, Seidman, J. G.
, Smith, J. A.
, and Struhl, K., eds)
, pp. 4.9.1-4.9.16, Wiley, New York
|
| 39.
|
Gersten, K. M.,
Natsuka, S.,
Trinchera, M.,
Petryniak, B.,
Kelly, R. J.,
Hiraiwa, N.,
Jenkins, N. A.,
Gilbert, D. J.,
Copeland, N. G.,
and Lowe, J. B.
(1995)
J. Biol. Chem.
270,
25047-25056
|
| 40.
|
Thall, A. D.,
Maly, P.,
and Lowe, J. B.
(1995)
J. Biol. Chem.
270,
21437-21440
|
| 41.
|
Nelson, J. F.,
Felicio, L. S.,
Randall, P. K.,
Sims, C.,
and Finch, C. E.
(1982)
Biol. Reprod.
27,
327-339
|
| 42.
|
Smith, P. L.,
Gersten, K. M.,
Petryniak, B.,
Kelly, R. J.,
Rogers, C.,
Natsuka, Y.,
Alford, J. A., 3rd,
Scheidegger, E. P.,
Natsuka, S.,
and Lowe, J. B.
(1996)
J. Biol. Chem.
271,
8250-8259
|
| 43.
|
Sternberg, N. L.
(1992)
Trends Genet.
8,
11-16
|
| 44.
|
Staudacher, E.,
Altmann, F.,
Wilson, I. B.,
and Marz, L.
(1999)
Biochim. Biophys. Acta
1473,
216-236
|
| 45.
|
Hitoshi, S.,
Kusunoki, S.,
Kanazawa, I.,
and Tsuji, S.
(1995)
J. Biol. Chem.
270,
8844-8850
|
| 46.
|
Hitoshi, S.,
Kusunoki, S.,
Kanazawa, I.,
and Tsuji, S.
(1996)
J. Biol. Chem.
271,
16975-16981
|
| 47.
|
Oriol, R.,
Mollicone, R.,
Cailleau, A.,
Balanzino, L.,
and Breton, C.
(1999)
Glycobiology
9,
323-334
|
| 48.
|
Hokke, C. H.,
Neeleman, A. P.,
Koeleman, C. A.,
and van den Eijnden, D. H.
(1998)
Glycobiology
8,
393-406
|
| 49.
|
Kimber, S. J.,
Illingworth, I. M.,
and Glasser, S. R.
(1995)
J. Reprod. Fertil.
103,
75-87
|
| 50.
|
Falk, P.,
Bry, L.,
Holgersson, J.,
and Gordon, J.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
1515-1519
|
| 51.
|
Bry, L.,
Falk, P.,
Midtvedt, T.,
and Gordon, J.
(1996)
Science
273,
1380-1383
|
| 52.
|
Ruggiero-Lopez, D.,
Biol, M. C.,
Louisot, P.,
and Martin, A.
(1991)
Biochem. J.
279,
801-806
|
| 53.
|
Biol, M.,
Lenoir, D.,
Hungueny, I.,
and Louisot, P.
(1992)
Biochim. Biophys. Acta
1133,
206-212
|
| 54.
|
Lenoir, D.,
Ruggiero-Lopez, D.,
Louisot, P.,
and Biol, M. C.
(1995)
Biochim. Biophys. Acta
1234,
29-36
|
| 55.
|
Umesaki, Y.,
Okada, Y.,
Matsumoto, S.,
Imaoka, A.,
and Setoyama, H.
(1995)
Microbiol. Immunol.
39,
555-562
|
| 56.
|
Clark, M.,
Jepson, M.,
Simmons, N.,
and Hirst, B.
(1995)
Cell Tissue Res.
282,
455-461
|
| 57.
|
Roy, M. J.
(1987)
Cell Tissue Res.
248,
483-489
|
| 58.
|
Bennett, G.
(1978)
Am. J. Anat.
152,
223-255
|
| 59.
|
Farr, A. G.,
and Anderson, S. K.
(1985)
J. Immunol.
134,
2971-2977
|
| 60.
|
Perillo, N. L.,
Pace, K. E.,
Seilhamer, J. J.,
and Baum, L. G.
(1995)
Nature
378,
736-739
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Nystrom, R. Norden, I. Muylaert, P. Elias, G. Larson, and S. Olofsson
Induction of sialyl-Lex expression by herpes simplex virus type 1 is dependent on viral immediate early RNA-activated transcription of host fucosyltransferase genes
Glycobiology,
August 1, 2009;
19(8):
847 - 859.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Nochi, Y. Yuki, A. Matsumura, M. Mejima, K. Terahara, D.-Y. Kim, S. Fukuyama, K. Iwatsuki-Horimoto, Y. Kawaoka, T. Kohda, et al.
A novel M cell specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses
J. Exp. Med.,
November 26, 2007;
204(12):
2789 - 2796.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Domino and E. A. Hurd
LacZ expression in Fut2-LacZ reporter mice reveals estrogen-regulated endocervical glandular expression during estrous cycle, hormone replacement, and pregnancy
Glycobiology,
February 1, 2004;
14(2):
169 - 175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Zheng, I. Van Die, and R. D. Cummings
Molecular Cloning and Characterization of a Novel alpha 1,2-Fucosyltransferase (CE2FT-1) from Caenorhabditis elegans
J. Biol. Chem.,
October 11, 2002;
277(42):
39823 - 39832.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Roos, M. Kolmer, P. Mattila, and R. Renkonen
Composition of Drosophila melanogaster Proteome Involved in Fucosylated Glycan Metabolism
J. Biol. Chem.,
January 25, 2002;
277(5):
3168 - 3175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Domino, L. Zhang, P. J. Gillespie, T. L. Saunders, and J. B. Lowe
Deficiency of Reproductive Tract alpha (1,2)Fucosylated Glycans and Normal Fertility in Mice with Targeted Deletions of the FUT1 or FUT2 alpha (1,2)Fucosyltransferase Locus
Mol. Cell. Biol.,
December 15, 2001;
21(24):
8336 - 8345.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|